Metabolomic Profiling of Faecal Extracts from Cryptosporidium parvum Infection in Experimental Mouse Models

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Ng Hublin, Josephine S Y ^a   Ryan, Una ^a   Trengove, Robert ^a   Maker, Garth ^a  

^a MURDOCH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CARBOHYDRATE; CARBOXYLIC ACID; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; FECES; INTESTINE MUCOSA PERMEABILITY; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; MOUSE; NEWBORN; NONHUMAN;

ANIMALS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; FECES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; METABOLOME; METABOLOMICS; MICE;

EID: 84885699959     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077803     Document Type: Article

References (31)

1. Xiao L, Ryan UM, (2008) Molecular Epidemiology. In: Fayer R, Xiao L, eds. Cryptosporidium and Cryptosporidiosis. 2nd Edition ed. Boca Raton, FL:: CRC Press. pp. pp. 119-170.
2. Rossignol J-F, (2010) Cryptosporidium and Giardia: Treatment options and prospects for new drugs. Exp Parasitol 124: 45-53. doi:10.1016/j.exppara.2009.07.005. PubMed: 19632225.
3. Xiao L, (2010) Molecular epidemiology of cryptosporidiosis: An update. Exp Parasitol 124: 80-89. doi:10.1016/j.exppara.2009.03.018. PubMed: 19358845.
4. Fayer R, Morgan U, Upton SJ, (2000) Epidemiology of Cryptosporidium: transmission, detection and identification. Int J Parasitol 30: 1305-1322. doi:10.1016/S0020-7519(00)00135-1. PubMed: 11113257.
5. Fall A, Thompson RCA, Hobbs RP, Morgan-Ryan U, (2003) Morphology is not a reliable tool for delineating species within Cryptosporidium. J Parasitol 89: 399-402. doi:10.1645/0022-3395(2003)089[0399:MINART]2.0.CO;2. PubMed: 12760666.
6. Weber R, Bryan RT, Bishop HS, Wahlquist SP, Sullivan JJ, et al. (1991) Threshold of detection of Cryptosporidium oocyst in human stool specimens: evidence for low sensitivty of current diagnostic methods. J Clin Microbiol 29: 1323-1327. PubMed: 1715881.
7. Li JV, Wang Y, Saric J, Nicholson JK, Dirnhofer S, et al. (2008) Global metabolic responses of NMRI mice to an experimental Plasmodium berghei Infection. J Proteome Res 7: 3948-3956. doi:10.1021/pr800209d. PubMed: 18646786.
8. Scheltema RA, Decuypere S, T'kindt R, Dujardin J-C, Coombs GH, et al. (2010) The potential of metabolomics for Leishmania research in the post-genomics era. Parasitology 137: 1291-1302. doi:10.1017/S0031182009992022. PubMed: 20109253.
9. Wang Y, Holmes E, Nicholson JK, Cloarec O, Chollet J, et al. (2004) Metabonomic investigations in mice infected with Schistosoma mansoni: An approach for biomarker identification. Proc Natl Acad Sci U S A 101: 12676-12681. doi:10.1073/pnas.0404878101. PubMed: 15314235.
10. Watson DG, (2010) The potential of mass spectrometry for the global profiling of parasite metabolomes. Parasitology 137: 1409-1423. doi:10.1017/S0031182009991648. PubMed: 20025826.
11. Fiehn O, (2001) Combining genomics, metabolome analysis and biochemical modelling to understand metabolic networks. Comp Funct Genomics 2: 155-168. doi:10.1002/cfg.82. PubMed: 18628911.
12. Ng JSY, Ryan U, Trengove RD, Maker GL, (2012) Development of an untargeted metabolomics method for the analysis of human faecal samples using Cryptosporidium-infected samples. Mol Biochem Parasitol 185: 145-150. doi:10.1016/j.molbiopara.2012.08.006. PubMed: 22944170.
13. Meloni BP, Thompson RC, (1996) Simplified methods for obtaining purified oocysts from mice and for growing Cryptosporidium parvum in vitro. J Parasitol 82: 757-762. doi:10.2307/3283888. PubMed: 8885885.
14. Leav BA, Mackay M, Ward HD, Acheson D, (2003) Cryptosporidium species: New insights and old challenges. Clin Infect Dis 36: 903-908. doi:10.1086/368194. PubMed: 12652391.
15. Gookin JL, Nordone SK, Argenzio RA, (2002) Host responses to Cryptosporidium infection. J Vet Intern Med 16: 12-21. doi:10.1111/j.1939-1676.2002.tb01602.x. PubMed: 11822801.
16. Capet C, Kapel N, Huneau JF, Magne D, Laikuen R, et al. (1999) Cryptosporidium parvum infection in suckling rats: Impairment of mucosal permeability and Na+-glucose cotransport. Exp Parasitol 91: 119-125. doi:10.1006/expr.1998.4358. PubMed: 9990339.
17. Topouchian A, Huneau JF, Barbot L, Rome S, Gobert JG, et al. (2003) Evidence for the absence of an intestinal adaptive mechanism to compensate for C. parvum-induced amino acid malabsorption in suckling rats. Parasitol Res 91: 197-203. doi:10.1007/s00436-003-0956-9. PubMed: 12923633.
18. Topouchian A, Kapel N, Larue-Achagiotis C, Barbot L, Tomé D, et al. (2005) Cryptosporidium infection impairs growth and muscular protein synthesis in suckling rats. Parasitol Res 96: 326-330. doi:10.1007/s00436-005-1369-8. PubMed: 15924222.
19. Abrahamsen MS, Templeton TJ, Enomoto S, Abrahante JE, Zhu G, et al. (2004) Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science 304: 441--445. doi:10.1126/science.1094786. PubMed: 15044751.
20. Vanee N, Roberts SB, Fong SS, Manque P, Buck GA, (2010) A genome-scale metabolic model of Cryptosporidium hominis. Chem Biodivers 7: 1026-1039. doi:10.1002/cbdv.200900323. PubMed: 20491062.
21. Xu P, Widmer G, Wang Y, Ozaki LS, Alves JM, et al. (2004) The genome of Cryptosporidium hominis. Nature 431: 1107-1112. doi:10.1038/nature02977. PubMed: 15510150.
22. Zhu G, (2008) Biochemistry. In: Fayer R, Xiao L, eds. Cryptosporidium and Cryptosporidiosis. 2nd ed. Boca Raton, FL:: CRC Press. pp. pp. 57-77.
23. Xu T, Ping J, Yu Y, Yu F, Yu Y, et al. (2010) Revealing parasite influence in metabolic pathways Apicomplexa infected patients. BMC Bioinformatics 11: S13.
24. Rider SD Jr, Zhu G, (2010) Cryptosporidium: Genomic and biochemical features. Exp Parasitol 124: 2-9. doi:10.1016/j.exppara.2008.12.014. PubMed: 19187778.
25. Vejchapipat P, Williams SR, Spitz L, Pierro A, (2000) Intestinal metabolism after ischemia-reperfusion. J Pediatr Surg 35: 759-764. doi:10.1053/jpsu.2000.6062. PubMed: 10813344.
26. Bridges JW, French MR, Smith RL, Williams RT, (1970) The fate of benzoic acid in various species. Biochem J 118: 47-51. PubMed: 4990586.
27. Krähenbühl L, Reichen J, Talos C, Krähenbühl S, (1997) Benzoic acid metabolism reflects hepatic mitochondrial function in rats with long-term extrahepatic cholestasis. Hepatology 25: 278-283. doi:10.1053/jhep.1997.v25.pm0009021934. PubMed: 9021934.
28. Fritzler JM, Millership JJ, Zhu G, (2007) Cryptosporidium parvum long-chain fatty acid elongase. Eukaryot Cell 6: 2018--2028. doi:10.1128/EC.00210-07. PubMed: 17827345.
29. Ehrenman K, Wanyiri JW, Bhat N, Ward HD, Coppens I, (2013) Cryptosporidium parvum scavenges LDL-derived cholesterol and micellar cholesterol internalized into enterocytes. Cell Microbiol 15: 1182-1197. doi:10.1111/cmi.12107. PubMed: 23311949.
30. Saric J, Wang Y, Li J, Coen M, Utzinger J, et al. (2007) Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J Proteome Res 7: 352-360. PubMed: 18052033.
31. Mauzy MJ, Enomoto S, Lancto CA, Abrahamsen MS, Rutherford MS, (2012) The Cryptosporidium parvum transcriptome during in vitro development. PLOS ONE 7: e31715. doi:10.1371/journal.pone.0031715. PubMed: 22438867.